Prostate Cancer - Results from #23280

Multidisciplinary care in patients with prostate cancer: Room for improvement - Abstract May 3, 2013

Early detection of prostate cancer: AUA Guideline May 3, 2013

The relationship between Agent Orange and prostate specific antigen: A comparison of a hotspot and a non-sprayed area in Vietnam - Abstract May 2, 2013

Predictive factors for premature discontinuation of docetaxel-based systemic chemotherapy in men with castration-resistant prostate cancer - Abstract May 2, 2013

Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: A systematic review and meta-analysis - Abstract May 2, 2013

A randomized controlled trial of a self-management psychosocial intervention for men with prostate cancer and their partners: A study protocol - Abstract May 2, 2013

MR imaging-guided focal cryoablation in patients with recurrent prostate cancer - Abstract May 2, 2013

Abiraterone acetate withdrawal syndrome: Does it exist? - Abstract May 2, 2013

Acute renal failure as the presenting sign of disseminated intravascular coagulation in a patient with metastatic prostate cancer - Abstract May 2, 2013

Transrectal quantitative shear wave elastography in the detection and characterisation of prostate cancer - Abstract May 2, 2013

Patterns and predictors of amelioration of genitourinary toxicity after high-dose intensity-modulated radiation therapy for localized prostate cancer: Implications for defining postradiotherapy urinary toxicity - Abstract May 1, 2013

Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance - Abstract May 1, 2013

Phase 3 study of adjuvant radiotherapy versus wait and see in pT3 prostate cancer: Impact of pathology review on analysis - Abstract May 1, 2013

Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: A step forward - Abstract May 1, 2013

Clinical judgment versus biomarker prostate cancer gene 3: Which is best when determining the need for repeat prostate biopsy? - Abstract May 1, 2013

Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors - Abstract May 1, 2013

Biochemical response to androgen deprivation therapy before external beam radiation therapy predicts long-term prostate cancer survival outcomes - Abstract May 1, 2013

Urinary biomarkers for prostate cancer: A review - Abstract May 1, 2013

Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen - Abstract May 1, 2013

2013 ASCO Annual Meeting press program announced May 1, 2013

Page 1165 of 1435